{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:34:50Z","timestamp":1780367690498,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05458-3","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T02:30:50Z","timestamp":1755052250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retrospective cohort study on alkaline phosphatase and ICU mortality rate of multiple myeloma"],"prefix":"10.1038","volume":"15","author":[{"given":"Qian-hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-xin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-bo","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"3","key":"5458_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.blre.2017.01.001","volume":"31","author":"E Kastritis","year":"2017","unstructured":"Kastritis, E. et al. The role of the bone microenvironment in multiple myeloma. Blood Rev. 31(3), 213\u2013223. https:\/\/doi.org\/10.1016\/j.blre.2017.01.001 (2017).","journal-title":"Blood Rev."},{"issue":"16","key":"5458_CR2","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman, G. D. Mechanisms of bone metastasis. N. Engl. J. Med. 350(16), 1655\u20131664. https:\/\/doi.org\/10.1056\/NEJMra030831 (2004).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"5458_CR3","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2006-05-026112","volume":"108","author":"N Giuliani","year":"2006","unstructured":"Giuliani, N. et al. Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. Blood 108(6), 2020\u20132027. https:\/\/doi.org\/10.1182\/blood-2006-05-026112 (2006).","journal-title":"Blood"},{"key":"5458_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3389\/fimmu.2017.00954","volume":"8","author":"A Mansour","year":"2017","unstructured":"Mansour, A. et al. Emerging roles of osteoclasts in the modulation of bone microenvironment and immune suppression in multiple myeloma. Front. Immunol. 8, 954. https:\/\/doi.org\/10.3389\/fimmu.2017.00954 (2017).","journal-title":"Front. Immunol."},{"issue":"12","key":"5458_CR5","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V. et al. International myeloma working group. Updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15(12), e538\u2013e548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5 (2014).","journal-title":"Lancet Oncol."},{"issue":"9","key":"5458_CR6","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-XIF:15.4Q1","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. The epidemiological landscape of multiple myeloma: A global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 9(9), e670\u2013e677. https:\/\/doi.org\/10.1016\/S2352-3026(22)00165-XIF:15.4Q1 (2022).","journal-title":"Lancet Haematol."},{"issue":"10","key":"5458_CR7","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/nu14102124","volume":"14","author":"M Haarhaus","year":"2022","unstructured":"Haarhaus, M. et al. Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease. Nutrients 14(10), 2124. https:\/\/doi.org\/10.3390\/nu14102124 (2022).","journal-title":"Nutrients"},{"issue":"1","key":"5458_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcb.20774IF:3.0Q3","volume":"98","author":"JP Stewart","year":"2006","unstructured":"Stewart, J. P. & Shaughnessy, J. D. Jr. Role of osteoblast suppression in multiple myeloma. J. Cell Biochem. 98(1), 1\u201313. https:\/\/doi.org\/10.1002\/jcb.20774IF:3.0Q3 (2006).","journal-title":"J. Cell Biochem."},{"key":"5458_CR9","first-page":"74","volume":"3","author":"SA Tutak","year":"2021","unstructured":"Tutak, S. A. Relationship between mortality and albumin, alkaline phosphatase, phosphorus and calcium values that may change with renal function and nutrition in intensive care setting. Anesth. Crit. Care 3, 74\u201382 (2021).","journal-title":"Anesth. Crit. Care"},{"issue":"1","key":"5458_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/16078454.2022.2095948","volume":"27","author":"Y Mao","year":"2022","unstructured":"Mao, Y., Zhu, S. & Geng, Y. Association between serum calcium and in-hospital mortality in critical patients with multiple myeloma: A cohort study. Hematology 27(1), 795\u2013801. https:\/\/doi.org\/10.1080\/16078454.2022.2095948 (2022).","journal-title":"Hematology"},{"key":"5458_CR11","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/ki.2010.189","volume":"117","author":"K Kalantar-Zadeh","year":"2010","unstructured":"Kalantar-Zadeh, K. et al. Kidney bone disease and mortality in CKD: Revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int. Suppl. 117, S10\u2013S21. https:\/\/doi.org\/10.1038\/ki.2010.189 (2010).","journal-title":"Kidney Int. Suppl."},{"issue":"2","key":"5458_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/ndt\/gfw412","volume":"33","author":"K Sumida","year":"2018","unstructured":"Sumida, K. et al. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol. Dial. Transplant. 33(2), 264\u2013273. https:\/\/doi.org\/10.1093\/ndt\/gfw412 (2018).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"5458_CR13","first-page":"42","volume":"73","author":"H Irisawa","year":"2015","unstructured":"Irisawa, H. Bone disease in multiple myeloma. Nihon Rinsho 73(1), 42\u201346 (2015).","journal-title":"Nihon Rinsho"},{"key":"5458_CR14","doi-asserted-by":"publisher","first-page":"100338","DOI":"10.1016\/j.jbo.2020.100338","volume":"26","author":"O Annibali","year":"2020","unstructured":"Annibali, O. et al. Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?. J. Bone Oncol. 26, 100338. https:\/\/doi.org\/10.1016\/j.jbo.2020.100338 (2020).","journal-title":"J. Bone Oncol."},{"issue":"1","key":"5458_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/16078454.2020.1845502","volume":"25","author":"X Diao","year":"2020","unstructured":"Diao, X., Cai, R., Luo, J., Zheng, Z. & Zhan, H. Prognostic factors for patients with multiple myeloma admitted to the intensive care unit. Hematology 25(1), 433\u2013437. https:\/\/doi.org\/10.1080\/16078454.2020.1845502 (2020).","journal-title":"Hematology"},{"issue":"23","key":"5458_CR16","doi-asserted-by":"publisher","first-page":"E215","DOI":"10.1161\/01.cir.101.23.e215","volume":"101","author":"AL Goldberger","year":"2000","unstructured":"Goldberger, A. L. et al. PhysioBank, PhysioToolkit, and PhysioNet: Components of a new research resource for complex physiologic signals. Circulation 101(23), E215-220. https:\/\/doi.org\/10.1161\/01.cir.101.23.e215 (2000).","journal-title":"Circulation"},{"issue":"6","key":"5458_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.12122\/j.issn.1673-4254.2020.06.01","volume":"40","author":"SO Huimin","year":"2020","unstructured":"Huimin, S. O., Jing, W. A., Chang, H. U., Chang, L. I. & Jianguo, L. I. Effects of cholestasis and hypoxic hepatitis on prognosis of ICU patients: A retrospective study based on MIMIC III database. J. South. Med. Univ. 40(6), 771\u2013777. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2020.06.01 (2020).","journal-title":"J. South. Med. Univ."},{"key":"5458_CR18","doi-asserted-by":"publisher","unstructured":"Full article: Association between serum calcium and in-hospital mortality in critical patients with multiple myeloma: a cohort study (no date). Available at: https:\/\/www.tandfonline.com\/doi\/full\/https:\/\/doi.org\/10.1080\/16078454.2022.2095948 (Accessed: 19 April 2024).","DOI":"10.1080\/16078454.2022.2095948"},{"issue":"1","key":"5458_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/jamia\/ocx084","volume":"25","author":"AE Johnson","year":"2018","unstructured":"Johnson, A. E. et al. \u2018The MIMIC code repository: Enabling reproducibility in critical care research. J. Am. Med. Inform. Assoc. JAMIA 25(1), 32\u201339. https:\/\/doi.org\/10.1093\/jamia\/ocx084 (2018).","journal-title":"J. Am. Med. Inform. Assoc. JAMIA"},{"issue":"3","key":"5458_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1590\/1413-785220162403157033","volume":"24","author":"JP Zum\u00e1rraga","year":"2016","unstructured":"Zum\u00e1rraga, J. P. et al. Serum values of alkaline phosphatase and lactate dehydrogenase in osteosarcoma. Acta Ortopedica Brasileira 24(3), 142\u2013146. https:\/\/doi.org\/10.1590\/1413-785220162403157033 (2016).","journal-title":"Acta Ortopedica Brasileira"},{"key":"5458_CR21","doi-asserted-by":"publisher","unstructured":"Le Gall, J. R., Lemeshow, S., Saulnier, F. A new simplified acute physiology score (SAPS II) based on a European\/North American multicenter study [published correction appears in JAMA 1994 May 4;271(17):1321]. JAMA 270(24), 2957-2963. https:\/\/doi.org\/10.1001\/jama.270.24.2957 (1993).","DOI":"10.1001\/jama.270.24.2957"},{"key":"5458_CR22","doi-asserted-by":"crossref","unstructured":"Wang, N., Wang, M., Jiang, L., Du, B., Zhu, B. & Xi, X. The predictive value of the oxford acute disease severity score for clinical outcomes in patients with acute kidney injury: A secondary analysis of a large prospective observational study (2021).","DOI":"10.21203\/rs.3.rs-640541\/v1"},{"issue":"6","key":"5458_CR23","doi-asserted-by":"publisher","first-page":"e0157361","DOI":"10.1371\/journal.pone.0157361","volume":"11","author":"SD Hwang","year":"2016","unstructured":"Hwang, S. D. et al. Serum alkaline phosphatase levels predict infection-related mortality and hospitalization in peritoneal dialysis patients. PLoS ONE 11(6), e0157361. https:\/\/doi.org\/10.1371\/journal.pone.0157361 (2016).","journal-title":"PLoS ONE"},{"key":"5458_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.640785","author":"Q Yang","year":"2021","unstructured":"Yang, Q. et al. Association between preadmission metformin use and outcomes in intensive care unit patients with sepsis and type 2 diabetes: A cohort study. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2021.640785 (2021).","journal-title":"Front. Med."},{"key":"5458_CR25","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.109.851873","volume":"120","author":"M Tonelli","year":"2009","unstructured":"Tonelli, M. et al. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120, 1784\u20131792 (2009).","journal-title":"Circulation"},{"issue":"8","key":"5458_CR26","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s00134-009-1511-7IF:27.1Q1","volume":"35","author":"SJ Thomson","year":"2009","unstructured":"Thomson, S. J. et al. \u201cLiver function tests\u201d on the intensive care unit: A prospective, observational study. Intensive Care Med. 35(8), 1406\u20131411. https:\/\/doi.org\/10.1007\/s00134-009-1511-7IF:27.1Q1 (2009).","journal-title":"Intensive Care Med."},{"key":"5458_CR27","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1182\/blood.V106.11.3457.3457","volume":"106","author":"U Heider","year":"2005","unstructured":"Heider, U. et al. Treatment of bortezomib increases osteoblast function in patients with multiple myeloma. Blood 106, 3457\u20133457 (2005).","journal-title":"Blood"},{"issue":"6","key":"5458_CR28","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1600-0609.2011.01602.x","volume":"86","author":"M Zangari","year":"2011","unstructured":"Zangari, M. et al. Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients. Eur. J. Haematol. 86(6), 484\u2013487. https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01602.x (2011).","journal-title":"Eur. J. Haematol."},{"issue":"9","key":"5458_CR29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/ajh.20961","volume":"82","author":"M Zangari","year":"2007","unstructured":"Zangari, M. et al. Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients. Am. J. Hematol. 82(9), 831\u2013833. https:\/\/doi.org\/10.1002\/ajh.20961 (2007).","journal-title":"Am. J. Hematol."},{"key":"5458_CR30","doi-asserted-by":"publisher","first-page":"9076647","DOI":"10.1155\/2023\/9076647","volume":"2023","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Investigation of the possible causes of NRBC in ICU patients and the dynamic trend of NRBC count in survival and death patients or with different underlying diseases: A retrospective study. Evid. Based Complement Altern. Med. 2023, 9076647. https:\/\/doi.org\/10.1155\/2023\/9076647 (2023).","journal-title":"Evid. Based Complement Altern. Med."},{"key":"5458_CR31","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1200\/jco.2006.24.18_suppl.7505","volume":"24","author":"J Berenson","year":"2006","unstructured":"Berenson, J. et al. Survival in patients with multiple myeloma receiving zoledronic acid: Stratification by baseline bone alkaline phosphatase levels. JCO 24, 7505\u20137505. https:\/\/doi.org\/10.1200\/jco.2006.24.18_suppl.7505 (2006).","journal-title":"JCO"},{"issue":"13","key":"5458_CR32","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","volume":"108","author":"N Giuliani","year":"2006","unstructured":"Giuliani, N., Rizzoli, V. & Roodman, G. D. Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. Blood 108(13), 3992\u20133996. https:\/\/doi.org\/10.1182\/blood-2006-05-026112 (2006).","journal-title":"Blood"},{"issue":"11","key":"5458_CR33","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.3390\/cancers14112768","volume":"14","author":"E Terpos","year":"2022","unstructured":"Terpos, E. et al. Daratumumab improves bone turnover in relapsed\/refractory multiple myeloma; phase 2 study \u201cREBUILD. Cancers 14(11), 2768. https:\/\/doi.org\/10.3390\/cancers14112768 (2022).","journal-title":"Cancers"},{"issue":"5","key":"5458_CR34","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.12669\/pjms.39.5.6815","volume":"39","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Man, Q.-H. & Li, C. Clinical efficacy of Thalidomide combined with PAD Regimen in patients with multiple Myeloma. Pak. J. Med. Sci. 39(5), 1243\u20131248. https:\/\/doi.org\/10.12669\/pjms.39.5.6815 (2023).","journal-title":"Pak. J. Med. Sci."},{"issue":"1","key":"5458_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3855\/jidc.18526","volume":"18","author":"B Tekin","year":"2024","unstructured":"Tekin, B. et al. The comparison of scoring systems: SOFA, APACHE-II, LODS, MODS, and SAPS-II in critically ill elderly sepsis patients. J. Infect. Dev. Ctries. 18(1), 122\u2013130. https:\/\/doi.org\/10.3855\/jidc.18526 (2024).","journal-title":"J. Infect. Dev. Ctries."},{"issue":"2","key":"5458_CR36","first-page":"197","volume":"26","author":"M Zhang","year":"2017","unstructured":"Zhang, M. et al. The value of Oxford acute severity score in severity assessment of critically Ill patients: A Single-center analysis based on 470 cases. China J. Emerg. Med. 26(2), 197\u2013201 (2017).","journal-title":"China J. Emerg. Med."},{"key":"5458_CR37","doi-asserted-by":"publisher","unstructured":"Performance on the APACHE II, SAPS II, SOFA and the OHCA score of post-cardiac arrest patients treated with therapeutic hypothermia|PLOS ONE (no date). Available at: https:\/\/journals.plos.org\/plosone\/article?id=https:\/\/doi.org\/10.1371\/journal.pone.0196197 (Accessed: 19 April 2024).","DOI":"10.1371\/journal.pone.0196197"},{"issue":"4","key":"5458_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/cc8016","volume":"13","author":"PA Hampshire","year":"2009","unstructured":"Hampshire, P. A. et al. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: A secondary analysis of the ICNARC Case Mix Programme Database. Crit. Care 13(4), 137. https:\/\/doi.org\/10.1186\/cc8016 (2009).","journal-title":"Crit. Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05458-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05458-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05458-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:27:23Z","timestamp":1757453243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05458-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5458"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05458-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The establishment of this database was approved by the Massachusetts Institute of Technology (Cambridge, MA) and Beth Israel Deaconess Medical Center (Boston, MA), and consent was obtained for the original data collection. Therefore, the ethical approval statement and the need for informed consent were waived for this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"There was no requirement of individual informed consent to extract data from the mimic-IV database because mimic-IV database information was publicly available and all patient data were deidentified.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"29623"}}